Tag: Zacks
Home infusion: Bioscrip to buy HomeChoice Partners
December 19, 2012HME News Staff
EDEN PRAIRIE, Minn. - BioScrip, a specialty pharmacy services provider based here, will acquire HomeChoice Partners for $70 million, in a move designed to strengthen its home infusion services, according to multiple reports. HomeChoice is an alternate-site infusion pharmacy services provider. The acquisition follows BioScrip's July purchase of InfuScience, also an alternate-site provider of home infusion services. Revenue for home infusion services have spiked 39.5% in the last reported quarter,...
BioScrip, HomeChoice Partners, InfuScience, Zacks
Sponsored Stories
How Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office